A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer
Clinical trial NCT02004093 · COMPLETED
Trial details
- NCT number
- NCT02004093
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-12-01
- Primary completion
- 2008-09-01
- Enrollment
- 149
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.